Alexandra Ellervik
Contacto de Relaciones con Inversores en CHOSA ONCOLOGY AB .
Perfil
Alexandra Ellervik is currently the Head of Communication & Investor Relations at Chosa Oncology AB.
Previously, she worked as an Investor Relations & Press Contact at RhoVac AB.
Cargos activos de Alexandra Ellervik
| Empresas | Cargo | Inicio |
|---|---|---|
| CHOSA ONCOLOGY AB | Contacto de Relaciones con Inversores | - |
Antiguos cargos conocidos de Alexandra Ellervik.
| Empresas | Cargo | Fin |
|---|---|---|
| CHOSA ONCOLOGY AB | Contacto de Relaciones con Inversores | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CHOSA ONCOLOGY AB | Commercial Services |
| Empresas privadas | 1 |
|---|---|
RhoVac AB
 RhoVac AB BiotechnologyHealth Technology RhoVac AB opertaes as biotechnology company that engages in the research and development of immunotherapy. The firm develops therapeutic cancer vaccines. Its main focus is the development of a drug with the potential to prevent or limit the metastasis of metastatic cancers. The company was founded by Bo Anders Ljungqvist, Per Thor Straten, and Mads Hald Andersen in November 2015 and is headquartered in Lund, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- Alexandra Ellervik